UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 251

Sortiert nach

Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition

Gene therapy, 2008-11, Vol.15 (21), p.1411-1423

2008

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of TGF-β signaling in genetically engineered tumor antigen-reactive T cells significantly enhances tumor treatment efficacy

Gene therapy, 2013-05, Vol.20 (5), p.575-580

2013

Link zum Volltext

Verfügbarkeit prüfen

Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: comparison of prophylaxis and therapy

The Journal of experimental medicine, 2001-08, Vol.194 (4), p.481-490

2001

Link zum Volltext

Verfügbarkeit prüfen

DNA and RNA-based vaccines: principles, progress and prospects

Vaccine, 1999-12, Vol.18 (9), p.765-777

1999

Link zum Volltext

Verfügbarkeit prüfen

Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens

JNCI : Journal of the National Cancer Institute, 1998-12, Vol.90 (24), p.1894-1900

1998

Link zum Volltext

Verfügbarkeit prüfen

Cancer immunotherapy: moving beyond current vaccines

Nature medicine, 2004-09, Vol.10 (9), p.909-915

2004

Link zum Volltext

Verfügbarkeit prüfen

Loss of Functional Beta2-Microglobulin in Metastatic Melanomas From Five Patients Receiving Immunotherapy

JNCI : Journal of the National Cancer Institute, 1996-01, Vol.88 (2), p.100-108

1996

Link zum Volltext

Verfügbarkeit prüfen

Enhanced T-cell activation and differentiation in lymphocytes from transgenic mice expressing ubiquitination-resistant 2KR LAT molecules

Gene therapy, 2015-10, Vol.22 (10), p.781-792

2015

Link zum Volltext

Verfügbarkeit prüfen

Countering the 'counterattack' hypothesis

Nature medicine, 2001-03, Vol.7 (3), p.259-259

Restifo, Nicholas P

2001

Link zum Volltext

Verfügbarkeit prüfen

The promise of nucleic acid vaccines

Gene therapy, 2000, Vol.7 (2), p.89-92

2000

Link zum Volltext

Verfügbarkeit prüfen

Identification of human cancers deficient in antigen processing

The Journal of experimental medicine, 1993-02, Vol.177 (2), p.265-272

1993

Link zum Volltext

Verfügbarkeit prüfen

Molecular Characterization of Defective Antigen Processing in Human Prostate Cancer

JNCI : Journal of the National Cancer Institute, 1995-02, Vol.87 (4), p.280-285

1995

Link zum Volltext

Verfügbarkeit prüfen

Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy

Trends in immunology, 2005-02, Vol.26 (2), p.111-117

2005

Link zum Volltext

Verfügbarkeit prüfen

Enhancement of tumor-specific immune response with plasmid DNA replicon vectors

Cancer research (Chicago, Ill.), 2000, Vol.60 (1), p.51-55

2000

Link zum Volltext

Verfügbarkeit prüfen

Enhancing Efficacy of Recombinant Anticancer Vaccines With Prime/Boost Regimens That Use Two Different Vectors

JNCI : Journal of the National Cancer Institute, 1997-11, Vol.89 (21), p.1595-1601

1997

Link zum Volltext

Verfügbarkeit prüfen

Cancer Regression and Autoimmunity Induced by Cytotoxic T Lymphocyte-Associated Antigen 4 Blockade in Patients with Metastatic Melanoma

Proceedings of the National Academy of Sciences - PNAS, 2003-07, Vol.100 (14), p.8372-8377

2003

Link zum Volltext

Verfügbarkeit prüfen

Intensity of the Vaccine-Elicited Immune Response Determines Tumor Clearance

The Journal of immunology (1950), 2002-01, Vol.168 (1), p.338-347

2002

Link zum Volltext

Verfügbarkeit prüfen

Cancer Regression and Autoimmunity in Patients after Clonal Repopulation with Antitumor Lymphocytes

Science (American Association for the Advancement of Science), 2002-10, Vol.298 (5594), p.850-854

2002

Link zum Volltext

Verfügbarkeit prüfen

Human melanoma cells do not express Fas (Apo-1/CD95) ligand

Cancer research (Chicago, Ill.), 1999, Vol.59 (1), p.59-62

1999

Link zum Volltext

Verfügbarkeit prüfen

Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape

Nature medicine, 2000-05, Vol.6 (5), p.493-495

Restifo, Nicholas P

2000

Link zum Volltext

Verfügbarkeit prüfen

Genetic vaccination with self tyrosinase-related protein 2 causes melanoma eradication but not vitiligo

Cancer research (Chicago, Ill.), 2000-01, Vol.60 (2), p.253-258

2000

Link zum Volltext

Verfügbarkeit prüfen

Less is more: lymphodepletion followed by hematopoietic stem cell transplant augments adoptive T-cell-based anti-tumor immunotherapy

Current opinion in immunology, 2005-04, Vol.17 (2), p.195-201

2005

Link zum Volltext

Verfügbarkeit prüfen

Identification of a CD11b+/Gr-1+/CD31+ myeloid progenitor capable of activating or suppressing CD8+T cells

Blood, 2000-12, Vol.96 (12), p.3838-3846

2000

Link zum Volltext

Verfügbarkeit prüfen

Murine tumor cells transduced with the gene for tumor necrosis factor-alpha. Evidence for paracrine immune effects of tumor necrosis factor against tumors

The Journal of immunology (1950), 1991-05, Vol.146 (9), p.3227

1991

Link zum Volltext

Verfügbarkeit prüfen

Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways

Nature medicine, 2003-01, Vol.9 (1), p.33-39

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 251

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(241)
Mit Volltextzugriff
(200)

Publikationsform

Artikel
(249)
Tagungsberichte
(2)

Sprache

Englisch
(251)
Japanisch
(23)

Erscheinungsjahr

n.n

Thema

Science & Technology
(185)
Life Sciences & Biomedicine
(169)
Animals
(137)
Humans
(122)
Mice
(114)
Immunology
(97)
Immunotherapy
(75)
Female
(73)
Oncology
(69)
Biological And Medical Sciences
(65)
Medicine, Research & Experimental
(63)
Research & Experimental Medicine
(63)
Medical Sciences
(55)
Mice, Inbred C57bl
(50)
Cd8-Positive T-Lymphocytes - Immunology
(49)
Melanoma - Immunology
(48)
Tumors
(48)
Antigens, Neoplasm - Immunology
(39)
Tumor Cells, Cultured
(39)
Cancer
(36)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition

Inhibition of TGF-β signaling in genetically engineered tumor antigen-reactive T cells significantly enhances tumor treatment efficacy

Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: comparison of prophylaxis and therapy

DNA and RNA-based vaccines: principles, progress and prospects

Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens

Cancer immunotherapy: moving beyond current vaccines

Loss of Functional Beta2-Microglobulin in Metastatic Melanomas From Five Patients Receiving Immunotherapy

Enhanced T-cell activation and differentiation in lymphocytes from transgenic mice expressing ubiquitination-resistant 2KR LAT molecules

Countering the 'counterattack' hypothesis

The promise of nucleic acid vaccines

Identification of human cancers deficient in antigen processing

Molecular Characterization of Defective Antigen Processing in Human Prostate Cancer

Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy

Enhancement of tumor-specific immune response with plasmid DNA replicon vectors

Enhancing Efficacy of Recombinant Anticancer Vaccines With Prime/Boost Regimens That Use Two Different Vectors

Cancer Regression and Autoimmunity Induced by Cytotoxic T Lymphocyte-Associated Antigen 4 Blockade in Patients with Metastatic Melanoma

Intensity of the Vaccine-Elicited Immune Response Determines Tumor Clearance

Cancer Regression and Autoimmunity in Patients after Clonal Repopulation with Antitumor Lymphocytes

Human melanoma cells do not express Fas (Apo-1/CD95) ligand

Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape

Genetic vaccination with self tyrosinase-related protein 2 causes melanoma eradication but not vitiligo

Less is more: lymphodepletion followed by hematopoietic stem cell transplant augments adoptive T-cell-based anti-tumor immunotherapy

Identification of a CD11b+/Gr-1+/CD31+ myeloid progenitor capable of activating or suppressing CD8+T cells

Murine tumor cells transduced with the gene for tumor necrosis factor-alpha. Evidence for paracrine immune effects of tumor necrosis factor against tumors

Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways

Suchergebnisse filtern